首页> 外文OA文献 >Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase.
【2h】

Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase.

机译:环孢菌素抑制Ca2(+)诱导的肝脏和心脏线粒体的大幅度肿胀可能是由于抑制剂与线粒体基质肽-脯氨酰顺反异构酶结合并阻止其与腺嘌呤核苷酸转位酶相互作用而引起的。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Isolated rat liver and heart mitochondria incubated in 150 mM-KSCN or sucrose medium in the presence of respiratory-chain inhibitors showed a large increase in swelling when exposed to 250 microM-Ca2+. Swelling was inhibited by bongkrekic acid and cyclosporin A in both media and by ADP in KSCN medium; the effect of ADP was reversed by carboxyatractyloside. These results demonstrate that this is a suitable technique with which to study the opening of the Ca2(+)-induced non-specific pore of the mitochondrial inner membrane and implicate the adenine nucleotide carrier in this process. 2. Titration of the rate of swelling with increasing concentrations of cyclosporin showed the number of cyclosporin-binding sites (+/- S.E.M.) in liver and heart mitochondria to be respectively 113.7 +/- 5.0 (n = 9) and 124.3 +/- 11.2 (n = 10) pmol/mg of protein, with a Ki of about 5 nM. 3. Liver and heart mitochondrial-matrix fractions were prepared free of membrane and cytosolic contamination and shown to contain cyclosporin-sensitive peptidyl-prolyl cis-trans isomerase (cyclophilin) activity. Titration of isomerase activity with cyclosporin gave values (+/- S.E.M.) of 110.6 +/- 10.1 (n = 5) and 165.4 +/- 15.0 (n = 3) pmol of enzyme/mg of liver and heart mitochondrial protein respectively, with a Ki of 2.5 nM. The similarity of these results to those from the swelling experiments suggest that the isomerase may be involved in the Ca2(+)-induced swelling. 4. The rapid light-scattering change induced in energized heart mitochondria exposed to submicromolar Ca2+ [Halestrap (1987) Biochem. J. 244, 159-164] was inhibited by ADP and bongkrekic acid, the former effect being reversed by carboxyatractyloside. These results suggest an interaction of Ca2+ with the adenine nucleotide carrier when the 'c' conformation. 5. A model is proposed in which mitochondrial peptidyl-prolyl cis-trans isomerase interacts with the adenine nucleotide carrier in the presence of Ca2+ to cause non-specific pore opening. The model also explains the involvement of the adenine nucleotide translocase in the PPi-mediated cyclosporin-insensitive increase in K+ permeability described in the preceding paper [Davidson & Halestrap (1990) Biochem. J. 268, 147-152]. 6. The physiological and pathological implications of the model are discussed in relation to reperfusion injury and cyclosporin toxicity.
机译:1.在存在呼吸链抑制剂的情况下,在150 mM-KSCN或蔗糖培养基中孵育的分离的大鼠肝脏和心脏线粒体,暴露于250 microM-Ca2 +时,肿胀大大增加。在两种培养基中,邦克里奇酸和环孢菌素A均抑制肿胀;在KSCN培养基中,ADP抑制肿胀;羧基白术苷逆转了ADP的作用。这些结果表明,这是一种合适的技术,可用于研究Ca2(+)诱导的线粒体内膜的非特异性孔的开放并在此过程中牵涉腺嘌呤核苷酸载体。 2.随着环孢菌素浓度的增加,溶胀速率的滴定表明肝和心脏线粒体中环孢菌素结合位点的数量分别为113.7 +/- 5.0(n = 9)和124.3 +/- 11.2(n = 10)pmol / mg蛋白质,Ki约为5 nM。 3.制备无膜和胞质污染的肝和心脏线粒体基质级分,并显示其具有环孢菌素敏感性肽基-脯氨酰顺反异构酶(亲环蛋白)活性。用环孢菌素滴定异构酶活性的值(+/- SEM)为110.6 +/- 10.1(n = 5)和165.4 +/- 15.0(n = 3)pmol酶/ mg肝和心脏线粒体蛋白, Ki为2.5 nM。这些结果与溶胀实验的结果相似,表明异构酶可能与Ca2(+)诱导的溶胀有关。 4.在暴露于亚微摩尔Ca2 +的充满活力的心脏线粒体中诱导的快速光散射变化[Halestrap(1987)Biochem。 [J. 244,159-164]被ADP和邦克里奇酸抑制,前者的作用被羧基白术苷逆转。这些结果表明,当“ c”构象时,Ca 2+与腺嘌呤核苷酸载体相互作用。 5.提出了一种模型,其中在Ca 2+存在下,线粒体肽基-脯氨酰顺反异构酶与腺嘌呤核苷酸载体相互作用,引起非特异性的孔开放。该模型还解释了腺嘌呤核苷酸转位酶参与了PPi介导的对环孢菌素不敏感的K +渗透性的增加,见先前的论文[Davidson&Halestrap(1990)Biochem。 J. 268,147-152]。 6.讨论了与再灌注损伤和环孢菌素毒性有关的模型的生理和病理意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号